Table of contents

Original Articles

• Adenovirus 5 E1a-mediated gene therapy for human ovarian cancer cells in vitro and in vivo

  (1 January, 2001)

  R.-Y. Zang, D.-R. Shi, H.-J. Lu, S.-M. Cai, D.-R. Lu, Y.-J. Zhang, H.-L. Qin
• Cervical cancer in Canada: Changing patterns in incidence and mortality (1 January, 2001)

  A. Probert, S. Liu, R. Semenciw, Y. Mao
• Limb sparing surgery for vulvar groin recurrence: A case report and review of the literature (1 January, 2001)

  B.-U. Sevin, B. Abendstein, W. A. Oldenburg, M. O'Connor, J. Waldorf, J. P. Klingler, M. J. Knudsen
• The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University (1 January, 2001)

  H. Pilch, S. Günzel, U. Schäffer, B. Tanner, P. Brockerhoff, M. Maeurer, M. Höckel, G. Hommel, P. G. Knapstein
• Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma (1 January, 2001)

  J. J. Jobsen, E. M. J. Schutter, J. H. Meerwaldt, J. Van Der Palen, R. Van Der Sijde, L. Naudin Ten Cate
• Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines (1 January, 2001)

  K. K. Berry, M. L. Varney, B. J. Dave, C. D. Bucana, I. J. Fidler, R. K. Singh
• High dose rate intracavitary brachytherapy for recurrent or residual lesions in the vaginal cuff: Results in post-hysterectomy patients with carcinoma of the cervix (1 January, 2001)

  I. Ogino, T. Kitamura, N. Okamoto, H. Nakayama, S. Matsubara
• Primary fallopian tube carcinoma: the Queensland experience (1 January, 2001)

  A. Obermair, K. H. Taylor, M. Janda, J. L. Nicklin, A. J. Crandon, L. Perrin